Introduction
Larinject 50mg Injection is a prescription medication manufactured by La Renon Healthcare Pvt Ltd. It contains the active ingredient Ferric Carboxymaltose in a strength of 50mg per vial. This medicine is commonly used to treat iron deficiency anemia.
Uses
Iron deficiency anemia is a condition characterized by a lack of iron in the body, leading to a reduced production of red blood cells. Larinject 50mg Injection is used to help restore iron levels in individuals with this condition, improving their overall health and energy levels.
Price
The maximum retail price (MRP) for Larinject 50mg Injection is ₹1740 per vial.
Dosage
It is important to follow your healthcare provider’s instructions on the dosage and administration of Larinject 50mg Injection. Typically, the medication is administered by a doctor or nurse through intravenous injection. Patients should not self-administer this medication.
Benefits
The benefits of using Larinject 50mg Injection include the effective treatment of iron deficiency anemia, leading to improved red blood cell production and overall health. By restoring iron levels in the body, patients may experience increased energy levels and reduced symptoms of anemia.
Side Effects
Some common side effects of Larinject 50mg Injection may include:
– Vomiting
– Headache
– Dizziness
– High blood pressure
– Injection site reactions (pain, swelling, redness)
– Nausea
– Dark colored stool
Patients should consult their healthcare provider if these side effects persist or worsen.
Active Ingredients
The active ingredient in Larinject 50mg Injection is Ferric Carboxymaltose, which is a form of iron used to treat iron deficiency anemia.
Pharmacological Properties
Ferric Carboxymaltose works by replenishing iron stores in the body, which is essential for the production of hemoglobin and red blood cells. This helps in correcting the anemia by increasing the hemoglobin levels in the blood.
Indications
Larinject 50mg Injection is indicated for the treatment of iron deficiency anemia in patients who have not responded to oral iron supplementation or have difficulty absorbing iron from the diet.
Contraindications
Patients with a known hypersensitivity to Ferric Carboxymaltose or any other ingredients in Larinject 50mg Injection should not use this medication. Additionally, individuals with certain medical conditions such as hemochromatosis or thalassemia should avoid this treatment.
Drug Interactions
There may be potential drug interactions with Larinject 50mg Injection and other medications. Patients should inform their healthcare provider about all the medicines they are currently taking, including prescription, over-the-counter, and herbal supplements.
Patient Counseling
Patients should be advised to follow their healthcare provider’s instructions on the use of Larinject 50mg Injection. It is important not to self-administer this medication and to report any persistent or severe side effects to the healthcare team.
Clinical Evidence
Clinical studies have shown that Ferric Carboxymaltose, the active ingredient in Larinject 50mg Injection, is effective in treating iron deficiency anemia and improving hemoglobin levels in patients who are unable to tolerate oral iron supplements.
Frequently Asked Questions
Q: Can I self-administer Larinject 50mg Injection?
A: No, it is important to have this medication administered by a healthcare professional.
Q: How long does it take to see the effects of Larinject 50mg Injection?
A: The effects of Larinject 50mg Injection may vary from person to person, but improvements in symptoms of iron deficiency anemia can be seen within a few weeks of starting treatment.
Q: Are there any dietary restrictions while using Larinject 50mg Injection?
A: Patients are advised to follow a diet rich in iron-containing foods to support the treatment, but specific restrictions may vary based on individual health needs.
Q: What should I do if I miss a dose of Larinject 50mg Injection?
A: Contact your healthcare provider to discuss how to proceed if you miss a scheduled dose of Larinject 50mg Injection.
Q: Is Larinject 50mg Injection habit-forming?
A: No, Larinject 50mg Injection is not habit-forming.
MRP:
₹1740
Manufacturer:
La Renon Healthcare Pvt Ltd
Salt:
Ferric Carboxymaltose (50mg),
How to UseLarinject 50mg Injection:
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Side Effects of Larinject 50mg Injection:
Vomiting,Headache,Dizziness,High blood pressure,Injection site reactions (pain, swelling, redness),Nausea,Dark colored stool,
Alternate Medicines for Larinject 50mg Injection:
Prescription Required Status:
Prescription Required
Type of Selection:
10 ml in 1 vial
Chemical Class:
Iron Carbohydrate Complex
Habit Forming:
No
Therapeutic Class:
GYNAECOLOGICAL
Action Class:
Haemopoetic agents
. Please note, this information is for educational purposes only and not intended as medical advice.